Skip to main content
Top

18-04-2024 | Vesicorenal Reflux | Case Report

Distal renal tubular acidosis as a rare complication of vesicoureteral reflux in children: a case report and literature review

Author: Emre Leventoğlu

Published in: CEN Case Reports

Login to get access

Abstract

Distal renal tubular acidosis (dRTA) is a clinical picture of hyperchloremic hypokalemic metabolic acidosis with a normal anion gap. It can be caused by a variety of conditions including obstructive uropathy such as vesicoureteral reflux (VUR). We report a rare case of dRTA secondary to VUR in a 4-year-old girl with a history of meningomyelocele, neurogenic bladder and recurrent urinary tract infections. She was admitted to the hospital with complaints of polydipsia, polyuria, and inability to gain weight for the last 1 year. She was on prophylactic antibiotic treatment with clean intermittent catheterization and anticholinergic drug. She had a history of subureteral injection of various agents and botulin toxin injection into the bladder. Her voiding cystourethrogram revealed grade 5 VUR in the left kidney, tortuosity in the left ureter, and the bladder had a dome-like appearance and was trabeculated. When all laboratory values of the patient since birth were examined, it was observed that urine pH was high despite hypokalemic hyperchloremic metabolic acidosis for the last year; these abnormalities became more severe in the last few months. In conclusion, the development of hypokalemia and nephrolithiasis/nephrocalcinosis along with metabolic acidosis in a patient diagnosed with VUR should be considered as an indicator of impaired tubular functions. Also, the possibility of an underlying VUR in the presence of recurrent urinary tract infection in a patient diagnosed with dRTA should not be ignored.
Literature
2.
3.
go back to reference Giglio S, Montini G, Trepiccione F, Gambaro G, Emma F. Distal renal tubular acidosis: a systematic approach from diagnosis to treatment. J Nephrol. 2021;34:2073–83.CrossRefPubMedPubMedCentral Giglio S, Montini G, Trepiccione F, Gambaro G, Emma F. Distal renal tubular acidosis: a systematic approach from diagnosis to treatment. J Nephrol. 2021;34:2073–83.CrossRefPubMedPubMedCentral
4.
go back to reference Wagner CA, Unwin R, Lopez-Garcia SC, Kleta R, Bockenhauer D, Walsh S. The pathophysiology of distal renal tubular acidosis. Nat Rev Nephrol. 2023;19:384–400.CrossRefPubMed Wagner CA, Unwin R, Lopez-Garcia SC, Kleta R, Bockenhauer D, Walsh S. The pathophysiology of distal renal tubular acidosis. Nat Rev Nephrol. 2023;19:384–400.CrossRefPubMed
5.
go back to reference Dönmez O, Filiz K. Renal tubuler asidoz. Güncel Pediatri. 2004;2(1):58–63. Dönmez O, Filiz K. Renal tubuler asidoz. Güncel Pediatri. 2004;2(1):58–63.
6.
go back to reference Gluck SL. Acid-base. Lancet. 1998;352:474–9. Gluck SL. Acid-base. Lancet. 1998;352:474–9.
7.
go back to reference Rodríguez SJ. Renal tubular acidosis: the clinical entity. J Am Soc Nephrol. 2002;13:2160–70.CrossRef Rodríguez SJ. Renal tubular acidosis: the clinical entity. J Am Soc Nephrol. 2002;13:2160–70.CrossRef
8.
go back to reference Laing CM, Toye AM, Capasso G, Unwin RJ. Renal tubular acidosis: developments in our understanding of the molecular basis. Int J Biochem Cell Biol. 2005;37:1151–61.CrossRefPubMed Laing CM, Toye AM, Capasso G, Unwin RJ. Renal tubular acidosis: developments in our understanding of the molecular basis. Int J Biochem Cell Biol. 2005;37:1151–61.CrossRefPubMed
9.
go back to reference Besouw MTP, Bienias M, Walsh P, et al. Clinical and molecular aspects of distal renal tubular acidosis in children. Pediatr Nephrol. 2017;32:987–96.CrossRefPubMed Besouw MTP, Bienias M, Walsh P, et al. Clinical and molecular aspects of distal renal tubular acidosis in children. Pediatr Nephrol. 2017;32:987–96.CrossRefPubMed
10.
go back to reference Vallés PG, Batlle D. Hypokalemic distal renal tubular acidosis. Adv Chronic Kidney Dis. 2018;25:303–20.CrossRefPubMed Vallés PG, Batlle D. Hypokalemic distal renal tubular acidosis. Adv Chronic Kidney Dis. 2018;25:303–20.CrossRefPubMed
11.
go back to reference Peters C, Rushton HG. Vesicoureteral reflux associated renal damage: congenital reflux nephropathy and acquired renal scarring. J Urol. 2010;184:265–73.CrossRefPubMed Peters C, Rushton HG. Vesicoureteral reflux associated renal damage: congenital reflux nephropathy and acquired renal scarring. J Urol. 2010;184:265–73.CrossRefPubMed
13.
go back to reference Jiménez-Hereza JM, Heras-Gironella M, Loris-Pablo C, Garagorri-Otero J, Tardós-Solano MJ. Monitorización ambulatoria de la presión arterial en un grupo de niños con nefropatía por reflujo de diferente grado [Ambulatory monitoring of arterial pressure in a group of children with reflux nephropathy of different degrees]. An Esp Pediatr. 1998;49:461–6.PubMed Jiménez-Hereza JM, Heras-Gironella M, Loris-Pablo C, Garagorri-Otero J, Tardós-Solano MJ. Monitorización ambulatoria de la presión arterial en un grupo de niños con nefropatía por reflujo de diferente grado [Ambulatory monitoring of arterial pressure in a group of children with reflux nephropathy of different degrees]. An Esp Pediatr. 1998;49:461–6.PubMed
14.
go back to reference Zhang YY, Bailey RR. A model of sterile vesicoureteric reflux in the sheep. Pediatr Nephrol. 1998;12:190–6.CrossRefPubMed Zhang YY, Bailey RR. A model of sterile vesicoureteric reflux in the sheep. Pediatr Nephrol. 1998;12:190–6.CrossRefPubMed
15.
go back to reference Gobet R, Cisek LJ, Chang B, Barnewolt CE, Retik AB, Peters CA. Experimental fetal vesicoureteral reflux induces renal tubular and glomerular damage, and is associated with persistent bladder instability. J Urol. 1999;162:1090–5.CrossRefPubMed Gobet R, Cisek LJ, Chang B, Barnewolt CE, Retik AB, Peters CA. Experimental fetal vesicoureteral reflux induces renal tubular and glomerular damage, and is associated with persistent bladder instability. J Urol. 1999;162:1090–5.CrossRefPubMed
16.
go back to reference Bharani A, Bharani T, Bharani R. Distal renal tubular acidosis secondary to vesico-ureteric reflux: a case report with review of literature. Saudi J Kidney Dis Transpl. 2018;29:1240–4.CrossRefPubMed Bharani A, Bharani T, Bharani R. Distal renal tubular acidosis secondary to vesico-ureteric reflux: a case report with review of literature. Saudi J Kidney Dis Transpl. 2018;29:1240–4.CrossRefPubMed
17.
go back to reference Chandar J, Abitbol C, Zilleruelo G, Gosalbez R, Montané B, Strauss J. Renal tubular abnormalities in infants with hydronephrosis. J Urol. 1996;155:660–3.CrossRefPubMed Chandar J, Abitbol C, Zilleruelo G, Gosalbez R, Montané B, Strauss J. Renal tubular abnormalities in infants with hydronephrosis. J Urol. 1996;155:660–3.CrossRefPubMed
18.
go back to reference Sharma RK, Jha R, Bhatia VL, Kapoor R, Gupta A. Secondary distal renal tubular acidosis in association with urological abnormalities. Nephrol Dial Transplant. 1997;12:233.CrossRefPubMed Sharma RK, Jha R, Bhatia VL, Kapoor R, Gupta A. Secondary distal renal tubular acidosis in association with urological abnormalities. Nephrol Dial Transplant. 1997;12:233.CrossRefPubMed
19.
go back to reference Santoso DN, Sinuraya FAG, Ambarsari CG. Distal renal tubular acidosis presenting with an acute hypokalemic paralysis in an older child with severe vesicoureteral reflux and syringomyelia: a case report. BMC Nephrol. 2022;23:248.CrossRefPubMedPubMedCentral Santoso DN, Sinuraya FAG, Ambarsari CG. Distal renal tubular acidosis presenting with an acute hypokalemic paralysis in an older child with severe vesicoureteral reflux and syringomyelia: a case report. BMC Nephrol. 2022;23:248.CrossRefPubMedPubMedCentral
Metadata
Title
Distal renal tubular acidosis as a rare complication of vesicoureteral reflux in children: a case report and literature review
Author
Emre Leventoğlu
Publication date
18-04-2024
Publisher
Springer Nature Singapore
Published in
CEN Case Reports
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-024-00873-3
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine